378 related articles for article (PubMed ID: 29180628)
1. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
Liu J; Zhang C; Zhao Y; Yue X; Wu H; Huang S; Chen J; Tomsky K; Xie H; Khella CA; Gatza ML; Xia D; Gao J; White E; Haffty BG; Hu W; Feng Z
Nat Commun; 2017 Nov; 8(1):1823. PubMed ID: 29180628
[TBL] [Abstract][Full Text] [Related]
2. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
[TBL] [Abstract][Full Text] [Related]
3. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.
Lai HH; Li JN; Wang MY; Huang HY; Croce CM; Sun HL; Lyu YJ; Kang JW; Chiu CF; Hung MC; Suzuki HI; Chen PS
J Clin Invest; 2018 Feb; 128(2):625-643. PubMed ID: 29251629
[TBL] [Abstract][Full Text] [Related]
5. K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression.
Wu HT; Kuo YC; Hung JJ; Huang CH; Chen WY; Chou TY; Chen Y; Chen YJ; Chen YJ; Cheng WC; Teng SC; Wu KJ
Nat Commun; 2016 Dec; 7():13644. PubMed ID: 27934968
[TBL] [Abstract][Full Text] [Related]
6. TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer.
Li JN; Chen PS; Chiu CF; Lyu YJ; Lo C; Tsai LW; Wang MY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008634
[TBL] [Abstract][Full Text] [Related]
7. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
8. UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.
Wang Y; Liu X; Wang M; Wang Y; Wang S; Jin L; Liu M; Zhou J; Chen Y
Oncogene; 2023 Nov; 42(46):3394-3406. PubMed ID: 37783786
[TBL] [Abstract][Full Text] [Related]
9. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
Luo W; Zhong J; Chang R; Hu H; Pandey A; Semenza GL
J Biol Chem; 2010 Feb; 285(6):3651-3663. PubMed ID: 19940151
[TBL] [Abstract][Full Text] [Related]
10. A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
Jia Y; Guo Y; Jin Q; Qu H; Qi D; Song P; Zhang X; Wang X; Xu W; Dong Y; Liang Y; Quan C
J Exp Clin Cancer Res; 2020 Feb; 39(1):42. PubMed ID: 32093760
[TBL] [Abstract][Full Text] [Related]
11. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
Ju UI; Park JW; Park HS; Kim SJ; Chun YS
Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
[TBL] [Abstract][Full Text] [Related]
12. VBP1 represses cancer metastasis by enhancing HIF-1α degradation induced by pVHL.
Kim JA; Choi DK; Min JS; Kang I; Kim JC; Kim S; Ahn JK
FEBS J; 2018 Jan; 285(1):115-126. PubMed ID: 29121446
[TBL] [Abstract][Full Text] [Related]
13. [Impact of hypoxia-inducible factor-1 on tumor invasion and metastasis in breast cancer].
Wang F; Chang MM; Zhao J; Jiang LL; Shi YH
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):99-103. PubMed ID: 21426805
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
15. Nijmegen breakage syndrome protein 1 (NBS1) modulates hypoxia inducible factor-1α (HIF-1α) stability and promotes in vitro migration and invasion under ionizing radiation.
Kuo YC; Wu HT; Hung JJ; Chou TY; Teng SC; Wu KJ
Int J Biochem Cell Biol; 2015 Jul; 64():229-38. PubMed ID: 25959252
[TBL] [Abstract][Full Text] [Related]
16. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
Cheng Y; Li W; Liu Y; Cheng HC; Ma J; Qiu L
Chin J Cancer; 2012 May; 31(5):248-56. PubMed ID: 22507221
[TBL] [Abstract][Full Text] [Related]
17. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
18. Bishonokiol A inhibits breast cancer cell invasion and migration by suppressing hypoxia inducible factor-1α.
Li HM; Miao J; Zhu M; Gao M; Dai Y; Huo Q; Ma T; Wu CZ
J Bioenerg Biomembr; 2019 Jun; 51(3):239-248. PubMed ID: 31062127
[TBL] [Abstract][Full Text] [Related]
19. Activation of hypoxia-inducible factor-1α by prolonged in vivo hyperinsulinemia treatment potentiates cancerous progression in estrogen receptor-positive breast cancer cells.
Wang L; Fan J; Yan CY; Ling R; Yun J
Biochem Biophys Res Commun; 2017 Sep; 491(2):545-551. PubMed ID: 28351619
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
